SourceOne Global Partners LLC has presented two new patented Cholesstrinol formulations with Cholesstrinol HP and Cholesstrinol HPe. "We have taken a quantum leap from the original formula to Cholesstrinol HP and Cholesstrinol HPe,” said Jesse Lopez, founder and CEO of SourceOne, by more than doubling the potency of PMF-Source citrus polymethoxylated flavones (PMFs) and TocoSource palm tocotrienols while delivering a broader flavonoid profile in both formulas. Supporting the ingredient’s potential, a study in Alternative Therapies in Health and Medicine
examined PMF-source and TocoSource palm tocotrienols branded Sytrinol showed significant improvements in total cholesterol (-30%), LDL (-27%), and triglycerides (-34%), compared to placebo, in human subjects. In addition, HDL levels increased 4%, resulting in a significant 29% improvement in the LDL:HDL ratio.
For further information: www.source-1-global.com